Clyde Hosein, Director at DENTSPLY SIRONA Inc. (XRAY), bought 6,500 shares at $9.98 ($65K) on 2026-06-15, disclosed to the SEC on 2026-06-16.
Director Clyde Hosein purchased 6,500 shares for $64,902, marking the largest purchase of his career and the fourth insider buy in the last 30 days, signaling confidence in the turnaround. The trade comes as the stock trades near its 52-week low following a Q2 earnings beat that was overshadowed by weak revenue guidance.
XRAY is down 34.46% over the last year and currently trades 38.91% below its 52-week high of $17.09, despite a 3.67% gain over the past 30 days.
Q2 2026 earnings on August 6, 2026, which saw a 44.44% earnings surprise; the upcoming Q3 2026 earnings on November 5, 2026; and the current insider buying momentum, with 4 other insiders purchasing shares in the last 30 days.
The stock faces headwinds from a 13.21% short interest percentage and recent analyst questions regarding lower sales volumes in key segments and regions, which contributed to a 6.8% stock drop following the Q2 earnings release.
Something here stands out, but not much.
| Filing → |
| CREE | SELL | 2021-02-22 | $3.5M | — | Filing → |
| RNG | SELL | 2017-05-02 | $6.4M | — | Filing → |
| RNG | SELL | 2016-12-15 | $3.6M | — | Filing → |